Ignite Creation Date:
2024-05-06 @ 1:40 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04085523
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-07
First Post:
2019-09-09
Brief Title:
A Dose Escalation Trial Evaluating Safety Efficacy and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia
Sponsor:
Ascendis Pharma AS
Organization:
Ascendis Pharma AS
Organization Data
Organization:
Ascendis Pharma AS
Class:
INDUSTRY
Study ID:
TCC-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ascendis Pharma AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None